David Santos
Corporate Officer/Principal bei RIGEL PHARMACEUTICALS, INC.
Vermögen: 516 658 $ am 31.03.2024
Profil
David A.
Santos currently works at Rigel Pharmaceuticals, Inc., as Chief Commercial Officer & Executive VP from 2020.
Mr. Santos also formerly worked at Amgen, Inc., as Vice President-Kinase Inhibitor, Pfizer Inc., as Vice President-Sales & Marketing, and Jazz Pharmaceuticals, Inc., as Head-Hematology.
Mr. Santos received his undergraduate degree from St. Louis University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.02.2024 | 349 093 ( 0,20% ) | 516 658 $ | 31.03.2024 |
Aktive Positionen von David Santos
| Unternehmen | Position | Beginn |
|---|---|---|
| RIGEL PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.08.2020 |
Ehemalige bekannte Positionen von David Santos
| Unternehmen | Position | Ende |
|---|---|---|
| PFIZER, INC. | Sales & Marketing | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
| AMGEN INC. | Corporate Officer/Principal | - |
Ausbildung von David Santos
| St. Louis University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| AMGEN INC. | Health Technology |
| PFIZER, INC. | Health Technology |
| RIGEL PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
